In a nutshell This study investigated the effect of tandem stem cell transplantation (SCT) in patients with high-risk relapsed/refractory Hodgkin Lymphoma (HL). The main finding was that patients treated with tandem SCT had greater progression-free survival than those without. Some background A SCT involves the transfer of stem cells into the patient to...Read More
Treatment(s) now being considered-Chemotherapy Posts on Medivizor
What are the outcomes for lymphoma patients who received TECAM chemotherapy before a stem cell transplant?
In a nutshell This study analyzed data from patients with Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma (NHL) who received TECAM (etoposide, thiotepa, cytarabine, cyclophosphamide, melphalan) chemotherapy before autoSCT (autologous stem cell transplantation). The authors concluded that TECAM is an effective pre-autoSCT regimen for...Read More
In a nutshell This study aimed to discover if docetaxel (Taxotere) added to androgen-deprivation therapy (ADT) increases overall survival for patients with metastatic hormone-sensitive prostate cancer. This study found that overall survival was higher for patients who received ADT and docetaxel compared to those who took ADT. Some...Read More
Can white blood cell count ratios help predict outcomes for newly diagnosed HL patients receiving PET2-mediated treatment?
In a nutshell This study investigated the impact of white blood cell counts on the outcomes of newly diagnosed Hodgkin’s lymphoma (HL) patients receiving treatment mediated by PET2 (PET scanning after 2 cycles of chemotherapy). This study concluded that ratios of different types of white blood cells combined with PET2 can be a meaningful...Read More
Does PET/CT scanning after one ABVD cycle better predict treatment outcomes than scanning after two cycles (iPET2)?
In a nutshell This study analyzed PET/CT scans from new Hodgkin’s lymphoma patients after one (iPET1) or two (iPET2) cycles of ABVD chemotherapy. The study concluded that iPET2 is better than iPET1 at predicting ABVD outcomes in HL patients. Some background Interem PET/CT scanning is used to guide early treatment for new Hodgkin’s...Read More
In a nutshell This study determined the outcomes of early-stage classical Hodgkin’s lymphoma (HL) patients who received ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) chemotherapy and radiotherapy (RT) only. The study concluded that patients who showed a good partial response (tumor shrinkage) to ABVD chemotherapy were successfully...Read More
In a nutshell This study investigated the safety of oxaliplatin to treat colorectal cancer in elderly patients. Researchers suggested that oxaliplatin treatment is associated with neuropathy (numbness of arms or legs) in these patients. Some background Colorectal cancer is one of the most common forms of cancer among the elderly....Read More
How safe and effective is combined brentuximab vedotin and bendamustine in patients with relapsed/refractory HL?
In a nutshell This study determined the safety and effectiveness of combined brentuximab vedotin (Adcetris) and bendamustine (Treanda) for relapsed or refractory (did not respond to treatment) Hodgkin’s lymphoma (HL). The study concluded that this combination is safe and effective, even for patients who already received intense anticancer...Read More
In a nutshell This study investigated the effectiveness of the chemotherapy FOLFOXIRI as treatment for colorectal cancer. Researchers suggested that this chemotherapy is associated with improved treatment outcomes. Some background Chemotherapy is used in cancer patients to reduce symptoms and prolong survival. Chemotherapy drugs attack cancer...Read More
In a nutshell This study examined outcomes for patients with Hodgkin lymphoma receiving chemotherapy followed by proton therapy. Researchers reported good disease control and a low rate of side effects at 3 years. However, continued follow-up is needed. Some background The combination of chemotherapy and radiation therapy provides the best...Read More
In a nutshell This study examined whether practicing Tibetan yoga during chemotherapy can benefit sleep quality. This study concluded that practicing twice a week or more led to greater long-term benefits over time. Some background Sleep disturbances and fatigue are common side effects reported by patients undergoing chemotherapy. This can...Read More
In a nutshell This study investigated the post-surgery factors that affect the use of chemotherapy after surgery in colorectal cancer patients. Researchers suggested that post-surgery complications are associated with delay or not receiving chemotherapy treatment. Some background Surgery and post-surgery chemotherapy are the standard...Read More